Lazard Asset Management LLC Eli Lilly & CO Transaction History

Lazard Asset Management LLC

$58.2 Billion
Q1 2025

A detailed history of Lazard Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lazard Asset Management LLC holds 779,893 shares of LLY stock, worth $488 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

779,893

Previous 678,051 15.02%

Holding current value

$488 Million

Previous $523 Million 23.05%

% of portfolio

1.11%

Previous 0.85%

48 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$725.72 - $929.72 $73.9 Million - $94.7 Million	101,842 Added 15.02%	779,893 $644 Million
Q4 2024 Feb 14, 2025	BUY	$727.2 - $932.06 $380 Million - $488 Million	523,237 Added 337.98%	678,051 $523 Million
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $66.7 Million - $82.9 Million	-86,345 Reduced 35.8%	154,814 $137 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $31.1 Million - $39 Million	-42,945 Reduced 15.12%	241,159 $218 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $19.8 Million - $26.4 Million	-33,362 Reduced 10.51%	284,104 $221 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $4.46 Million - $5.26 Million	-8,500 Reduced 2.61%	317,466 $185 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $4.52 Million - $6.23 Million	-10,389 Reduced 3.09%	325,966 $175 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $13.3 Million - $17.7 Million	-37,846 Reduced 10.11%	336,355 $158 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $2.84 Million - $3.34 Million	9,153 Added 2.51%	374,201 $129 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $2.18 Million - $2.54 Million	-6,778 Reduced 1.82%	365,048 $134 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $7.87 Million - $8.97 Million	-26,534 Reduced 6.66%	371,826 $120 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $12 Million - $14.1 Million	-43,182 Reduced 9.78%	398,360 $129 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $17.2 Million - $21.4 Million	-73,351 Reduced 14.25%	441,542 $126 Million
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $17.8 Million - $22 Million	-78,976 Reduced 13.3%	514,893 $142 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $106 Million - $130 Million	-478,168 Reduced 44.6%	593,869 $137 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $45.4 Million - $58.8 Million	251,693 Added 30.68%	1,072,037 $246 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $14 Million - $18.2 Million	85,344 Added 11.61%	820,344 $153 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $1.01 Million - $1.34 Million	-7,773 Reduced 1.05%	735,000 $124 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $24.5 Million - $28.3 Million	167,471 Added 29.11%	742,773 $110 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $2.45 Million - $2.95 Million	17,978 Added 3.23%	575,302 $94.5 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $169,170 - $209,384	1,421 Added 0.26%	557,324 $77.3 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $29.2 Million - $36.1 Million	-272,720 Reduced 32.91%	555,903 $73.1 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $8.7 Million - $9.46 Million	-81,478 Reduced 8.95%	828,623 $92.7 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $8.53 Million - $9.96 Million	-77,022 Reduced 7.8%	910,101 $101 Million
Q1 2019 Aug 28, 2019	SELL	$111.31 - $131.02 $14,470 - $17,032	-130 Reduced 0.01%	987,123 $128 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $7.54 Million - $8.88 Million	67,739 Added 7.37%	987,253 $128 Million
Q4 2018 Aug 28, 2019	SELL	$105.9 - $118.64 $163,827 - $183,536	-1,547 Reduced 0.17%	919,514 $106 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $16.7 Million - $18.7 Million	157,535 Added 20.63%	921,061 $107 Million
Q3 2018 Aug 30, 2019	SELL	$85.86 - $107.31 $82,597 - $103,232	-962 Reduced 0.13%	763,526 $81.9 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $10.4 Million - $13 Million	120,784 Added 18.76%	764,488 $82 Million
Q2 2018 Aug 30, 2019	SELL	$75.7 - $86.88 $52,914 - $60,729	-699 Reduced 0.11%	643,704 $54.9 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $12.6 Million - $14.4 Million	-166,013 Reduced 20.48%	644,403 $55 Million
Q1 2018 Aug 28, 2019	SELL	$74.21 - $87.6 $51,872 - $61,232	-699 Reduced 0.09%	810,416 $62.7 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $1.21 Million - $1.43 Million	-16,311 Reduced 1.97%	811,115 $62.8 Million
Q4 2017 Aug 28, 2019	BUY	$81.94 - $87.89 $45,968 - $49,306	561 Added 0.07%	827,426 $69.9 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $447,802 - $480,318	5,465 Added 0.67%	826,865 $69.8 Million
Q3 2017 Aug 19, 2019	BUY	$77.07 - $85.54 $74,912 - $83,144	972 Added 0.12%	821,400 $70.3 Million
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $26.2 Million - $29 Million	-339,336 Reduced 29.26%	820,428 $70.2 Million
Q2 2017 Aug 19, 2019	SELL	N/A	-27,019 Reduced 2.28%	1,159,764 $95.4 Million
Q1 2017 Aug 13, 2019	SELL	N/A	-75,909 Reduced 6.01%	1,186,783 $99.8 Million
Q4 2016 Jul 30, 2019	SELL	N/A	-1,969,746 Reduced 60.94%	1,262,692 $92.9 Million
Q3 2016 Aug 07, 2019	SELL	N/A	-628,473 Reduced 16.28%	3,232,438 $259 Million
Q2 2016 Jul 29, 2019	SELL	N/A	-145,428 Reduced 3.63%	3,860,911 $304 Million
Q1 2016 Jul 25, 2019	SELL	N/A	-621,739 Reduced 13.43%	4,006,339 $288 Million
Q4 2015 Jul 24, 2019	SELL	N/A	-1,076,174 Reduced 18.87%	4,628,078 $390 Million
Q3 2015 Jul 15, 2019	SELL	N/A	-1,001,357 Reduced 14.93%	5,704,252 $477 Million
Q2 2015 Jul 08, 2019	BUY	N/A	1,058,396 Added 18.74%	6,705,609 $560 Million
Q4 2014 Aug 29, 2019	BUY	N/A	5,647,213	5,647,213 $390 Million

Others Institutions Holding LLY

# of Institutions

4,400

Shares Held

756M

Call Options Held

9.9M

Put Options Held

10.9M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $594B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Eli Lilly & CO Transaction History